CPT code 30110 denotes surgical removal of a nasal polyp or polyps from the nasal cavity. The code captures a focused operative procedure aimed at relieving nasal obstruction and improving sinonasal function. Nationally, this procedure is common in otolaryngology practice and affects utilization patterns across commercial insurers and Medicare due to its procedural nature and frequent links to chronic rhinosinusitis and allergic disease management. Key payers in typical analyses include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical framing of the procedure, payer coverage context, and what to expect in benchmarking and policy discussion. The publication outlines standard coding identification, typical sites of service, and common payer considerations. It highlights benchmark metrics such as utilization rates, place-of-service distribution, and payment variability where available, and notes relevant policy trends that can influence prior authorization, medical necessity review, and site-of-service determinations. Data not available in the input is clearly marked when applicable.